Načítá se...
Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma
BACKGROUND: Drug resistance is still one of the key causes of death in epithelial ovarian carcinoma (EOC) patients, however there are very few strategies to reverse chemoresistance. Here we try to clarify whether and how miR-9 takes part in the regulation of paclitaxel sensitivity. METHODS: miR-9 ex...
Uloženo v:
| Vydáno v: | BMC Cancer |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4495847/ https://ncbi.nlm.nih.gov/pubmed/26152689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1509-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|